PREDICTORS OF EARLY SAPHENOUS-VEIN AORTOCORONARY BYPASS GRAFT OCCLUSION

被引:47
作者
PAZ, MA
LUPON, J
BOSCH, X
POMAR, JL
SANZ, G
机构
[1] UNIV BARCELONA,HOSP CLIN,DEPT CARDIOL,UNITAT CORONARIA,VILLARROEL 170,E-08036 BARCELONA,SPAIN
[2] UNIV BARCELONA,HOSP CLIN,DEPT CARDIOVASC SURG,BARCELONA 7,SPAIN
[3] HOSP GERMANS TRIAS,DEPT CARDIOL,BARCELONA,SPAIN
关键词
D O I
10.1016/0003-4975(95)90024-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To identify factors determining early saphenous vein aortocoronary bypass occlusion, we analyzed the data base of the GESIC study, a trial comparing antiplatelet drug regimens that included 927 patients with 1,854 saphenous vein grafts. The univariate analysis showed female sex (p < 0.0097), obesity (p < 0.001), rest angina (p < 0.0026), history of congestive heart failure (p < 0.037), the revascularized artery (p < 0.0001), the quality of distal bed (p < 0.00001), the diameter of the grafted vessel (p < 0.00001), the lack of antiaggregant treatment (p < 0.017), and a nonsequential technique (p < 0.0002) as predictors of early (28 days) graft occlusion. In the multivariate analysis the last five variables were independent predictors. Using the two preoperative variables, it was possible to identify groups at different risk; the occlusion rate ranged between 8.79% (left anterior descending coronary artery and good distal vessel) and 27.58% (right coronary artery or left circumflex coronary artery and poor distal vessel). The combination of three variables (grafted vessel, artery diameter, and antiaggregant treatment) also allowed identification of different risk groups; the occlusion rate ranged between 3.5% and 63.1%. Thus, it is possible to anticipate the risk of graft occlusion in patients undergoing coronary artery bypass grafting, which may help in the selection of both patients and antithrombotic treatment.
引用
收藏
页码:1101 / 1106
页数:6
相关论文
共 20 条
[1]   THE FUTURE OF SAPHENOUS-VEIN AS A CORONARY-ARTERY BYPASS CONDUIT [J].
ANGELINI, GD ;
NEWBY, AC .
EUROPEAN HEART JOURNAL, 1989, 10 (03) :273-280
[2]   THROMBOSIS AND ACCELERATED ATHEROSCLEROSIS IN CORONARY-BYPASS SURGERY AND RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - IMPLICATIONS FOR THERAPY [J].
BADIMON, JJ ;
IP, J ;
BADIMON, L ;
FUSTER, V .
CORONARY ARTERY DISEASE, 1990, 1 (02) :170-179
[3]  
BERNAL JM, 1991, CORONARY ARTERY DIS, V2, P713
[4]   EARLY AND LATE PATENCY OF AORTOCORONARY VEIN GRAFTS [J].
BJORK, VO ;
EKESTROM, S ;
HENZE, A ;
IVERT, T ;
LANDOU, C .
SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1981, 15 (01) :11-21
[5]  
BONCHEK LI, 1980, J THORAC CARDIOV SUR, V79, P911
[6]  
CAMPEAU L, 1983, CIRCULATION, V68, P1
[7]  
CATINELLA FP, 1982, J THORAC CARDIOV SUR, V83, P686
[8]   CRITICAL ANALYSIS OF THE PREOPERATIVE AND OPERATIVE PREDICTORS OF AORTOCORONARY BYPASS PATENCY [J].
CROSBY, IK ;
WELLONS, HA ;
TAYLOR, GJ ;
MAFFEO, CJ ;
BELLER, GA ;
MULLER, WH .
ANNALS OF SURGERY, 1981, 193 (06) :743-751
[9]   EFFICACY OF ANTI-PLATELET DRUGS IN THE MAINTENANCE OF AORTOCORONARY VEIN BYPASS GRAFT PATENCY [J].
GITLER, B ;
GITLER, ES .
AMERICAN HEART JOURNAL, 1983, 106 (03) :563-570
[10]  
HARJOLA PT, 1981, ANN CHIR GYNAECOL, V70, P191